TORNTPHARM
Torrent Pharmaceuticals Limited has disclosed, pursuant to SEBI regulations, that its Securities Transfer and Stakeholders Relationship Committee (STSRC) approved the issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) worth up to ₹12,500 crore through private placement. These NCDs, to be listed on the Wholesale Debt Market Segment of NSE, will have their tenure, allotment date, maturity date, and coupon rate determined at the time of issuance. The NCDs will be secured by a first-ranking exclusive charge over a designated account and specified trademarks, ensuring a minimum security cover of 1.1x. The rights and privileges of NCD holders will be detailed in the final debenture trust deed. No delays, defaults, or cancellations related to the issuance have been reported.

















